Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keryx
Keryx
Top Biotech Stock Picks for Q4 2013: An Interview with the Senior Analyst at Oppenheimer & Company
Yahoo/Wall St Transcript
Sat, 09/14/13 - 10:38 am
Amgen
Celgene
ONYX Pharmaceuticals
Keryx
Pluristem Therapeutics
NPS Pharmaceuticals
Don't Miss These 3 Healthcare Sweet Spots
Seeking Alpha
Sat, 08/24/13 - 11:44 am
Celldex
Keryx
Sarepta Therapeutics
Keryx's First Step Toward Zerenex Approval
Motley Fool
Sat, 08/10/13 - 12:40 pm
Keryx
Zerenex
chronic kidney disease
Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2013 Financial Results
MarketWatch
Thu, 08/1/13 - 09:35 am
Keryx
earnings
Keryx Biopharmaceuticals' Zerenex Likely To Receive FDA Approval
Seeking Alpha
Mon, 07/22/13 - 05:58 pm
Keryx
FDA
Zerenex
Sanofi
Shire
hyperphosphatemia
3 Biotechs With Strong Momentum - Can They Keep It Up?
Seeking Alpha
Wed, 06/19/13 - 03:57 pm
Acadia
Celldex
Keryx
Keryx Patents Seen Overcoming Generic Competition
Investors.com
Wed, 06/19/13 - 03:55 pm
Keryx
patents
generics
chronic kidney disease
Zerenex
Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You)
TheStreet.com
Tue, 06/11/13 - 10:14 am
Acadia
Clovis Oncology
MannKind
Chelsea Therapeutics
Keryx
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
Keryx announces positive Zerenex Phase 3 data
Yahoo/Fly on the Wall
Mon, 06/3/13 - 10:12 am
Zerenex
Keryx
hyperphosphatemia
BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
Seeking Alpha
Tue, 05/28/13 - 08:14 am
BioDelivery Sciences
Acadia
Amarin
Keryx
Insmed
opiod addiction
3 Biotech Stocks With Potential
Seeking Alpha
Tue, 05/14/13 - 10:13 am
Keryx
NeoStem
ImmunoCellular Therapeutics
Sarepta
Keryx: A Small Biotech With Many Catalysts
Seeking Alpha
Wed, 05/8/13 - 10:42 am
Keryx
3 Speculative Biotech Stocks to Buy Now
Motley Fool
Sat, 04/13/13 - 11:27 am
Sarepta Therapeutics
MannKind
Keryx
Biotech's Fallen Angels: Identifying Irrational Market Behavior
Seeking Alpha
Mon, 04/8/13 - 12:00 pm
Keryx
Acadia
Arena Pharmaceuticals
Sanuwave
FDA
What You Need To Know About Keryx And Zerenex's IP
Seeking Alpha
Mon, 04/8/13 - 11:25 am
Keryx
Zerenex
The Validity And Risk Of Keryx Biopharmaceuticals
Seeking Alpha
Thu, 03/21/13 - 10:50 am
Keryx
Keryx CEO vs. a Short-Seller: Zerenex Patent Debate
TheStreet.com
Wed, 03/13/13 - 12:17 pm
Keryx
Zerenex
patents
Amarin
The Best- And Worst-Performing Biotech Stocks In February
Forbes
Mon, 03/4/13 - 10:55 am
Optimer
Questcor
Celldex
OraSure
Pharmacyclics
Taro
Synta Pharmaceuticals
Keryx
Dynavax
Affymax
Why Expect More Price Swings From These 4 Biotechs
TheStreet.com
Thu, 02/28/13 - 11:26 am
Dendreon
Keryx
Oncolytics
Vivus
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »